Smart Drug Delivery Systems Market Growth Outlook Through 2024-2033

Overview and Scope
Smart drug delivery systems refer to advanced technologies designed to improve the efficacy, safety, and targeted delivery of pharmaceutical compounds to specific sites within the body. These systems employ various strategies to control the release of drugs, enhance bioavailability, and minimize side effects.

Sizing and Forecast
The smart drug delivery systems market size has grown rapidly in recent years. It will grow from $10.61 billion in 2023 to $12.65 billion in 2024 at a compound annual growth rate (CAGR) of 19.2%. The growth in the historic period can be attributed to increasing demand for drug delivery systems, rising patient compliance, rising prevalence of chronic diseases, increasing personalized medicine, and need for cost-effective healthcare solutions.

The smart drug delivery systems market size is expected to see rapid growth in the next few years. It will grow to $25.94 billion in 2028 at a compound annual growth rate (CAGR) of 19.7%. The growth in the forecast period can be attributed to growing burden of non-communicable diseases, increased focus on precision medicine, the rise of theragnostic, growing demand for non-invasive drug delivery methods, and increasing healthcare expenditure. Major trends in the forecast period include miniaturization and microfabrication technologies, advancements in material science, integration of artificial intelligence (AI) and machine learning (ML), development of nano-sized drug delivery systems, and integration of IoT and wearable technology.

To access more details regarding this report, visit the link:
https://www.thebusinessresearchcompany.com/report/smart-drug-delivery-systems-global-market-report

Segmentation & Regional Insights
The smart drug delivery systems market covered in this report is segmented –
1) By Product: Connected Inhalers, Connected Autoinjectors, Connected Pen Injectors, Connected Wearable Injectors, Add-On Sensors, Other Products
2) By Therapeutic Area: Metabolic Disorders, Neurological Disorders, Respiratory Disorders, Hormonal Disorders, Other Therapeutic Areas
3) By Drug Delivery Mode: Injectable, Inhalation, Oral
4) By End-User: Hospitals, Clinics, Home Care, Ambulatory Care Settings, Other End-Users

North America was the largest region in the smart drug delivery systems market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the smart drug delivery systems market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

Intrigued to explore the contents? Secure your hands-on sample copy of the report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=14796&type=smp

Major Driver Impacting Market Growth
The rising prevalence of chronic diseases is expected to propel the growth of the smart drug delivery systems market going forward. Chronic diseases are long-term health conditions that progress slowly over time and often have complex causes. The prevalence of chronic diseases is increasing due to aging populations, environmental influences, and disparities in healthcare access. Smart drug delivery systems offer a promising approach to managing chronic diseases by enhancing medication effectiveness and increasing patient adherence. For instance, in January 2023, according to the National Library of Medicine, the US-based medical library, by 2050, there will be 142.66 million people with at least one chronic illness, a 99.5% rise from 71.522 million in 2020. Therefore, the rising prevalence of chronic diseases is driving the smart drug delivery systems market.

Key Industry Players
Major companies operating in the smart drug delivery systems market are Pfizer Inc, Johnson & Johnson, Bayer AG, Abbott Laboratories, Novartis International AG, Medtronic plc, Eli Lilly and Company, Amgen Inc, Novo Nordisk, Merck Group, Becton Dickinson and Company, Stryker Corporation, Baxter International Inc, Boston Scientific Corporation, Biogen Inc, Vertex Pharmaceuticals Incorporated, Phillips-Medisize Corporation, ResMed Inc., West Pharmaceutical Services Inc, Insulet Corporation, Owen Mumford Ltd, Sonceboz, H&T Presspart Manufacturing Ltd, E3D Elcam Drug Delivery Devices, CeQur Corporation

The smart drug delivery systems market report table of contents includes:
1. Executive Summary